4/A
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001104659-21-141455
Director returned 14,887 shares (to the company)
- Director acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BARASCH RICHARD A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Exercise or conversion : show line 1 in the form | +100,000 | 100,000 | D |
| 2021-11-12 | Returned to the company : show line 2 in the form | −14,887 | 85,113 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Exercise or conversion : show line 3 in the form Class B Common Stock | −100,000 | 0 | D |
Loading xslF345X03/tm2133425-1_4aseq1.xml…